Why the study?
Does iron replacement and folic acid therapy with moderate exercise reduction improve outcomes in patients with hemolytic anemia following prosthetic valve replacement?
Does iron replacement and folic acid therapy with moderate exercise reduction improve outcomes in patients with hemolytic anemia following prosthetic valve replacement?
Answers are grounded in this paper and cite their sources.
Medical management with iron, folic acid, and exercise reduction provides an effective alternative to reoperation for patients with hemolytic anemia following prosthetic valve replacement.
Ten patients with marked hemolytic anemia secondary to prosthetic cardiac valve replacement are presented. Although the etiology of this disorder is not understood, available evidence supports the concept of blood destruction secondary to turbulence around valves as the primary factor. These studies illustrate the technical difficulties associated with reoperation and the disappointing results which often follow. Emphasis is placed on the role of iron replacement and folic acid therapy in association with moderate reduction in exercise. This regimen has produced gratifying results in the management of these patients.
No takes yet. Share an insight, caveat, or question.
Rodgers et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: